Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Anyang Tumor Hospital
h-index: 47
Total citations: 9,027
Total papers: 1,022
Recent papers from Anyang Tumor Hospital
Izalontamab Brengitecan in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: The PANKU-Esophagus01 Randomized Clinical Trial
JAMA · 2026
MFAP2⁺ CAF reprogramming promotes bladder cancer invasion and an immunosuppressive microenvironment
Cell Death and Disease · 2026
Benmelstobart With or Without Anlotinib After Chemoradiotherapy for Unresectable Non−Small Cell Lung Cancer
JAMA Oncology · 2026
Multi-omics profiling of esophagus basaloid squamous cell carcinoma reveals potential signatures for diagnosis and therapeutics
Heliyon · 2026
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer
New England Journal of Medicine · 2026
Optimal Sequencing of First‐Line Immune Checkpoint Inhibitors With Definitive Chemoradiotherapy: A Multicenter Real‐World Cohort Study Comparing Induction, Concurrent, and Consolidation Strategies for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
International Journal of Cancer · 2026
First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2–Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT)
Journal of Clinical Oncology · 2026
Recurrence Pattern and Prognostic Value of Major Pathological Response in Patients with Locally Advanced Oesophageal Squamous Cell Carcinoma Treated with Neoadjuvant Immunochemotherapy: A Multicentre Retrospective Study
Cancers · 2026
Benmelstobart plus antiangiogenic therapy vs chemotherapy for metastatic triple-negative breast cancer: phase III trial
npj Breast Cancer · 2026
Neoadjuvant Anbenitamab and HB1801 in ERBB2 -Positive Breast Cancer
JAMA Oncology · 2026
Camrelizumab plus nimotuzumab as second-line therapy for advanced esophageal squamous cell carcinoma: a multicenter phase II study
Journal for ImmunoTherapy of Cancer · 2026
Determinants of a positive resection margin (R1 status) in esophageal squamous cell carcinoma: a retrospective analysis of 148,121 cases from China
BMC Cancer · 2026
Multi-omics profiling reveals gene signatures and therapeutic targets in HER2-guided gastric cardia adenocarcinoma patients
Communications Biology · 2026
Biomarker-integrated machine learning models for predicting treatment-related bowel dysfunction after rectal cancer surgery: a multicenter development and external validation study
Frontiers in Medicine · 2026
Emerging neuroprotective mechanisms and therapeutic potential of natural polysaccharides in Alzheimer's disease
Frontiers in Aging Neuroscience · 2026
Development and external validation of two nomograms for predicting brain metastases and brain metastasis-free survival in primary small cell carcinoma of the esophagus: a retrospective multicenter analysis
Therapeutic Advances in Medical Oncology · 2026
Clinical Subphenotypes and Short-Term Outcomes in PICU Patients Receiving Continuous Blood Purification
Critical Care Explorations · 2026
An interpretable artificial intelligence model for real-time leukemia screening via routine blood tests across multicenter cohorts
npj Digital Medicine · 2026
Biocatalytic reduction of nitro-sulfonamides: enzyme engineering, process integration, and sustainable pathways to p-aminobenzenesulfonamide
Frontiers in Bioengineering and Biotechnology · 2026
Effect of endoscopic screening for non-cardia gastric cancer: a 12-year report of a population-based randomized trial
BMC Medicine · 2026